Age of biology requires American leadership
If the United States does not lead in emerging biotechnologies, our adversaries will, writes GOP Sen. Todd Young of Indiana.
Harvard Business Review12d
Navigating the New Geopolitics of Tech
synthetic biology, and quantum computing — are redefining global power dynamics, economics, and security frameworks. Second, ...
AgWeb4d
Indigo Ag and Truterra Form ‘Landmark Collaboration’ in Carbon
After being in the market alongside each other for four years, Truterra will begin offering Indigo Ag carbon programs, and ...
Asia One3d
CABIO Deepens Commitment to Global Markets, Aiming to Serve International Clients and Pursue Long-Term International Partnerships
CABIO, a high-tech enterprise underpinned by biotechnology and listed on the Science and Technology Innovation Board (stock ...
startup.siliconindia3d
Blue Wave Aquaculture : Revolutionizing the Seafood Supply Chain through Innovation
Blue Wave Aquaculture's primary product is high-quality fish for human consumption, with plans to export to international markets as well ...
Business Insider10d
Recursion and Exscientia Shareholders Approve the Proposed Combination
About Recursion Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery ... volatility in foreign currency exchange rates and supply chain disruptions; ...
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 ...
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus or the Company, Nasdaq: CHRS), today reported financial results for the quarter ended September 30, 2024 and ...
Finanznachrichten10d
Recursion Pharmaceuticals: Recursion and Exscientia Shareholders Approve the Proposed Combination
About Recursion Recursion is a leading clinical stage TechBio company decoding biology to industrialize drug discovery ... volatility in foreign currency exchange rates and supply chain disruptions; ...
The Globe and Mail12d
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
About BioAge Labs, Inc. BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human ...